Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AI124766, AI129147, AI145505)
Launch Tennessee SBIR/STTR Matching Fund
Received: 17 March 2020
Accepted: 26 October 2020
First Online: 12 November 2020
Ethics approval and consent to participate
: Protocols for obtaining volunteer blood samples were reviewed and approved by the Western Institutional Review Board (WIRB20171157). Study participants provided written informed consent.
: Not applicable.
: IQuity, Inc. is a company focused on developing RNA-based tools to aid in the diagnosis of chronic diseases, including autoimmune disease.